| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Minireview |
Department of Molecular Medicine (A.F.-M., G.N., E.R.-B.), Karolinska Institute, 17176 Stockholm, Sweden; and The Walter and Eliza Hall Institute of Medical Research (C.J.G.), Victoria 3050, Australia
Address all correspondence and requests for reprints to: Amilcar Flores-Morales, Center of Molecular Medicine (CMM), L8:01, Karolinska Hospital, 17176 Stockholm, Sweden. E-mail: Amilcar.Flores{at}cmm.ki.se.
GH has been of significant scientific interest for decades because of its capacity to dramatically change physiological growth parameters. Furthermore, GH interacts with a range of other hormonal pathways and is an established pharmacological agent for which novel therapeutical applications can be foreseen. It is easy to see the requirement for a number of postreceptor mechanisms to regulate and control target tissue sensitivity to this versatile hormone. In recent years, some of the components that take part in the down-regulatory mechanism targeting the activated GH receptor (GHR) have been defined, and the physiological significance of some of these key components has begun to be characterized. Down-regulation of the GHR is achieved through a complex mechanism that involves rapid ubiquitin-dependent endocytosis of the receptor, the action of tyrosine phosphatases, and the degradation by the proteasome. The suppressors of cytokine signaling (SOCS) protein family, particularly SOCS2, plays an important role in regulating GH actions. The aim of this review is to summarize collected knowledge, including very recent findings, regarding the intracellular mechanisms responsible for the GHR signaling down-regulation. Insights into these mechanisms can be of relevance to several aspects of GH research. It can help to understand growth-related disease conditions, to explain GH resistance, and may be used to develop pharmaceuticals that enhance some the beneficial actions of endogenously secreted GH in a tissue-specific manner.
This article has been cited by other articles:
![]() |
R. D. Meyer, E. V. Laz, T. Su, and D. J. Waxman Male-Specific Hepatic Bcl6: Growth Hormone-Induced Block of Transcription Elongation in Females and Binding to Target Genes Inversely Coordinated with STAT5 Mol. Endocrinol., November 1, 2009; 23(11): 1914 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Laz, A. Sugathan, and D. J. Waxman Dynamic in Vivo Binding of STAT5 to Growth Hormone-Regulated Genes in Intact Rat Liver. Sex-Specific Binding at Low- But Not High-Affinity STAT5 Sites Mol. Endocrinol., August 1, 2009; 23(8): 1242 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Gevers, M. J. Hannah, M. J. Waters, and I. C. A. F. Robinson Regulation of Rapid Signal Transducer and Activator of Transcription-5 Phosphorylation in the Resting Cells of the Growth Plate and in the Liver by Growth Hormone and Feeding Endocrinology, August 1, 2009; 150(8): 3627 - 3636. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, S. Sood, V. M. R. Krishnamurthy, P. Rotwein, and R. Rabkin Endotoxin-Induced Growth Hormone Resistance in Skeletal Muscle Endocrinology, August 1, 2009; 150(8): 3620 - 3626. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, S. Puzhko, M. Wabitsch, and C. G. Goodyer Transcriptional Regulation of the Human Growth Hormone Receptor (hGHR) Gene V2 Promoter by Transcriptional Activators and Repressor Mol. Endocrinol., March 1, 2009; 23(3): 373 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Buzzelli, M. Nagarajan, J. F. Radtka, M. L. Shumate, M. Navaratnarajah, C. H. Lang, and R. N. Cooney Nuclear Factor-{kappa}B Mediates the Inhibitory Effects of Tumor Necrosis Factor-{alpha} on Growth Hormone-Inducible Gene Expression in Liver Endocrinology, December 1, 2008; 149(12): 6378 - 6388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kenth, J. A M. Mergelas, and C. G. Goodyer Developmental changes in the human GH receptor and its signal transduction pathways J. Endocrinol., July 1, 2008; 198(1): 71 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pilecka, C. Patrignani, R. Pescini, M.-L. Curchod, D. Perrin, Y. Xue, J. Yasenchak, A. Clark, M. C. Magnone, P. Zaratin, et al. Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth J. Biol. Chem., November 30, 2007; 282(48): 35405 - 35415. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Uyttendaele, I. Lemmens, A. Verhee, A.-S. De Smet, J. Vandekerckhove, D. Lavens, F. Peelman, and J. Tavernier Mammalian Protein-Protein Interaction Trap (MAPPIT) Analysis of STAT5, CIS, and SOCS2 Interactions with the Growth Hormone Receptor Mol. Endocrinol., November 1, 2007; 21(11): 2821 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. van den Eijnden and G. J. Strous Autocrine Growth Hormone: Effects on Growth Hormone Receptor Trafficking and Signaling Mol. Endocrinol., November 1, 2007; 21(11): 2832 - 2846. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Rhoads, J W Kim, M E Van Amburgh, R A Ehrhardt, S J Frank, and Y R Boisclair Effect of nutrition on the GH responsiveness of liver and adipose tissue in dairy cows J. Endocrinol., October 1, 2007; 195(1): 49 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Elsasser, C.-J. Li, T. J. Caperna, S. Kahl, and W. F. Schmidt Growth Hormone (GH)-Associated Nitration of Janus Kinase-2 at the 1007Y-1008Y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a GH, AKT, and Nitric Oxide Synthase Axis on GH Signal Transduction Endocrinology, August 1, 2007; 148(8): 3792 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, Y. Wang, M. Wu, Z. Gu, S. J. Frank, and R. Torres-Diaz Growth Hormone Stimulates Hepatic Expression of Bovine Growth Hormone Receptor Messenger Ribonucleic Acid through Signal Transducer and Activator of Transcription 5 Activation of a Major Growth Hormone Receptor Gene Promoter Endocrinology, July 1, 2007; 148(7): 3307 - 3315. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Vidal, R. Merino, E. Rico-Bautista, L. Fernandez-Perez, D. J. Chia, J. Woelfle, M. Ono, B. Lenhard, G. Norstedt, P. Rotwein, et al. In Vivo Transcript Profiling and Phylogenetic Analysis Identifies Suppressor of Cytokine Signaling 2 as a Direct Signal Transducer and Activator of Transcription 5b Target in Liver Mol. Endocrinol., January 1, 2007; 21(1): 293 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Garma, C. Kobayashi, F. Haddad, G. R. Adams, P. W. Bodell, and K. M. Baldwin Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise J Appl Physiol, January 1, 2007; 102(1): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Pello, M. del Carmen Moreno-Ortiz, J. M. Rodriguez-Frade, L. Martinez-Munoz, D. Lucas, L. Gomez, P. Lucas, E. Samper, M. Aracil, C. Martinez-A, et al. SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade Blood, December 1, 2006; 108(12): 3928 - 3937. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hatanaka, Y. Hatanaka, and M. Setou Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2 J. Biol. Chem., November 24, 2006; 281(47): 35922 - 35930. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Waxman and C. O'Connor Growth Hormone Regulation of Sex-Dependent Liver Gene Expression Mol. Endocrinol., November 1, 2006; 20(11): 2613 - 2629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |